Salarius Pharmaceuticals to Attend the Oppenheimer Healthcare Conference
Salarius Pharmaceuticals, Inc. (SLRX)
Company Research
Source: GlobeNewswire
HOUSTON, March 02, 2020 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage oncology company targeting cancers caused by dysregulated gene expression, announced today that its chief executive officer, David Arthur, will be attending the 30th Annual Oppenheimer Healthcare Conference being held in New York City. Details of the conference are as follows: Event: Oppenheimer 30th Annual Healthcare ConferenceDates: Tuesday, March 17, 2020 and Wednesday, March 18, 2020Format: One-on-One Meetings Location: InterContinental New York Barclay Hotel, 111 E. 48th St., New York, NY The Oppenheimer Healthcare Conference brings together a broad spectrum of public and private healthcare companies, spanning all major sectors of the healthcare sector. Attendees will have the opportunity to interact with more than 180 company management teams and gain insight from key thought leaders on a variety of topical issues. Mr. Arthur will provide a corporate update highlight
Show less
Read more
Impact Snapshot
Event Time:
SLRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SLRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SLRX alerts
High impacting Salarius Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
SLRX
Sec Filings
- 12/23/24 - Form 8-K
- 12/16/24 - Form S-1
- 12/13/24 - Form 8-K
- SLRX's page on the SEC website